BiomEdit Announces USDA Finding of No Significant Impact Letter for Non-Antibiotic Poultry Biologic, Clearing Path to Field Safety Trials
FOR IMMEDIATE RELEASE BiomEdit Announces USDA Finding of No Significant Impact Letter for Non-Antibiotic Poultry Biologic, Clearing Path to Field Safety Trials Regulatory milestone allows product to proceed to final phase of USDA conditional licensure process for necrotic enteritis prevention in broiler chickens GREENFIELD, IND. (November 13, 2025) – BiomEdit, Inc., a pioneering animal health […]
BiomEdit Awarded Nearly $2 Million from Bezos Earth Fund to Advance AI Model for Methane-Reduction Strategies in Cattle
BiomEdit Awarded Nearly $2 Million from Bezos Earth Fund to Advance AI Model for Methane‑Reduction Strategies in Cattle Partnership with Bioversity International USA and Yale University will build the Rumen Digital Twin to model and optimize climate‑smart feed and microbiome interventions GREENFIELD, IND. (Oct. 23, 2025) – In partnership with Bioversity International USA and Yale […]
BiomEdit Advances First-of-Its-Kind Engineered Bacteria Product to Final Development Phase, Secures Series B Funding and Adds Key Industry Leadership
BiomEdit Advances First-of-Its-Kind Engineered Bacteria Product to Final Development Phase, Secures Series B Funding and Adds Key Industry Leadership Poultry industry’s first engineered probiotic biologic moves into final development and regulatory stagesfor USDA conditional licensure and commercial scale-up GREENFIELD, IND. (July 16, 2025) – BiomEdit, a pioneering animal health biotechnology company, today announced a significant […]
BiomEdit Announces Advancement of a First-of-Its-Kind Engineered Bacteria Product into Full Pivotal Development to Combat Necrotic Enteritis in Broiler Chickens
BiomEdit Announces Advancement of a First-of-Its-Kind Engineered Bacteria Product into Full Pivotal Development to Combat Necrotic Enteritis in Broiler Chickens Product to provide non-antibiotic alternative to prevent deadly and costly poultry disease FISHERS, IND. (February 15, 2024) – BiomEdit, an emerging animal health biotechnology company, today announced the advancement of a first-of-its-kind engineered bacteria product […]
BiomEdit’s Aaron Schacht Named Visionary CEO in S&P Global Animal Health Awards
BiomEdit’s Aaron Schacht Named Visionary CEO in S&P Global Animal Health Award Award marks second year BiomEdit recognized by S&P Global since previously awarded Best Start-Up in 2022 FISHERS, IND. (January 9, 2024) – BiomEdit CEO Aaron Schacht was recently named 2023 Visionary CEO in the S&P Global Animal Health Awards for his role in […]
Researchers of New Scientific Review Paper Call for Additional Research to Fill Critical Gaps in Understanding Methane-Producing Microbes in Gut of Livestock
Researchers of New Scientific Review Paper Call for Additional Research to Fill Critical Gaps in Understanding Methane-Producing Microbes in Gut of Livestock Additional research is key to developing solutions that work with livestock’s own microbiome to reduce methane emissions and increase feed efficiency to tackle climate change and food security FISHERS, IND. (November 16, 2023) […]
BiomEdit Awarded Grant to Develop Microbiome-Based Solution to Reduce Methane Emissions and Enhance Production Efficiency of Cattle in Africa and South Asia
BiomEdit Awarded Grant to Develop Microbiome-Based Solution to Reduce Methane Emissions and Enhance Production Efficiency of Cattle in Africa and South Asia Animal health biotech BiomEdit and Bill & Melinda Gates Foundation work together to mitigate the contribution of cattle to agricultural greenhouse gases (GHG) while increasing food security and the economic livelihood of small-scale […]
Indiana Biosciences Research Institute and BiomEdit Announce Integrated Drug Discovery Collaboration
Indiana Biosciences Research Institute and BiomEdit Announce Integrated Drug Discovery Collaboration The partnership will enable the development of new engineered medicines to address unmet needs in animal health INDIANAPOLIS, IND. (August 22, 2023) – The Indiana Biosciences Research Institute (IBRI), a leading translational research organization, is pleased to announce an integrated drug discovery collaboration with BiomEdit, […]
